Stevens Capital Management LP / ALXN
Stevens Capital Management LP’s Alexion Pharmaceuticals Inc Position
Does Stevens Capital Management LP own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 76.8K shares worth $10M in Q2 2019; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$10M
Q2 2019
Shares
76.8K
% of Portfolio
+0.45%
Quarters Held
3
position exited
Position History ALXN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stevens Capital Management LP’s full portfolio or all institutional holders of ALXN.